BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 27052831)

  • 1. Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing.
    Kang X; He W; Huang Y; Yu Q; Chen Y; Gao X; Sun X; Fan Y
    J Assist Reprod Genet; 2016 May; 33(5):581-588. PubMed ID: 27052831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of concentration of CRISPR/Cas9 components on genetic mosaicism in cytoplasmic microinjected porcine embryos.
    Tanihara F; Hirata M; Nguyen NT; LE QA; Hirano T; Otoi T
    J Reprod Dev; 2019 Jun; 65(3):209-214. PubMed ID: 30726783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing the efficiency of CRISPR/Cas9-mediated precise genome editing in rats by inhibiting NHEJ and using Cas9 protein.
    Ma Y; Chen W; Zhang X; Yu L; Dong W; Pan S; Gao S; Huang X; Zhang L
    RNA Biol; 2016 Jul; 13(7):605-12. PubMed ID: 27163284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the potential of genome editing CRISPR-Cas9 technology.
    Singh V; Braddick D; Dhar PK
    Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes.
    Liang P; Xu Y; Zhang X; Ding C; Huang R; Zhang Z; Lv J; Xie X; Chen Y; Li Y; Sun Y; Bai Y; Songyang Z; Ma W; Zhou C; Huang J
    Protein Cell; 2015 May; 6(5):363-372. PubMed ID: 25894090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.
    Zhang X; Wang L; Liu M; Li D
    Sci China Life Sci; 2017 May; 60(5):468-475. PubMed ID: 28534255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient Genome Editing in Apple Using a CRISPR/Cas9 system.
    Nishitani C; Hirai N; Komori S; Wada M; Okada K; Osakabe K; Yamamoto T; Osakabe Y
    Sci Rep; 2016 Aug; 6():31481. PubMed ID: 27530958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome editing of CCR5 by CRISPR-Cas9 in Mauritian cynomolgus macaque embryos.
    Schmidt JK; Strelchenko N; Park MA; Kim YH; Mean KD; Schotzko ML; Kang HJ; Golos TG; Slukvin II
    Sci Rep; 2020 Oct; 10(1):18457. PubMed ID: 33116147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient genome editing in cultured cells and embryos of Debao pig and swamp buffalo using the CRISPR/Cas9 system.
    Su X; Cui K; Du S; Li H; Lu F; Shi D; Liu Q
    In Vitro Cell Dev Biol Anim; 2018 May; 54(5):375-383. PubMed ID: 29556895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene editing in human development: ethical concerns and practical applications.
    Rossant J
    Development; 2018 Jul; 145(16):. PubMed ID: 30045910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple genome modifications by the CRISPR/Cas9 system in zebrafish.
    Ota S; Hisano Y; Ikawa Y; Kawahara A
    Genes Cells; 2014 Jul; 19(7):555-64. PubMed ID: 24848337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards a CRISPR view of early human development: applications, limitations and ethical concerns of genome editing in human embryos.
    Plaza Reyes A; Lanner F
    Development; 2017 Jan; 144(1):3-7. PubMed ID: 28049687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein.
    Tang L; Zeng Y; Du H; Gong M; Peng J; Zhang B; Lei M; Zhao F; Wang W; Li X; Liu J
    Mol Genet Genomics; 2017 Jun; 292(3):525-533. PubMed ID: 28251317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish.
    Hruscha A; Krawitz P; Rechenberg A; Heinrich V; Hecht J; Haass C; Schmid B
    Development; 2013 Dec; 140(24):4982-7. PubMed ID: 24257628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient edition of the bovine PRNP prion gene in somatic cells and IVF embryos using the CRISPR/Cas9 system.
    Bevacqua RJ; Fernandez-Martín R; Savy V; Canel NG; Gismondi MI; Kues WA; Carlson DF; Fahrenkrug SC; Niemann H; Taboga OA; Ferraris S; Salamone DF
    Theriogenology; 2016 Nov; 86(8):1886-1896.e1. PubMed ID: 27566851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. After the Storm - A Responsible Path for Genome Editing.
    Daley GQ; Lovell-Badge R; Steffann J
    N Engl J Med; 2019 Mar; 380(10):897-899. PubMed ID: 30649993
    [No Abstract]   [Full Text] [Related]  

  • 18. [CRISPR-Cas9, germinal cells and human embryo].
    Jouannet P
    Biol Aujourdhui; 2017; 211(3):207-213. PubMed ID: 29412130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of mutation rates, mosaicism and off target mutations when injecting Cas9 mRNA or protein for genome editing of bovine embryos.
    Hennig SL; Owen JR; Lin JC; Young AE; Ross PJ; Van Eenennaam AL; Murray JD
    Sci Rep; 2020 Dec; 10(1):22309. PubMed ID: 33339870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The application of CRISPR-Cas9 genome editing in Caenorhabditis elegans.
    Xu S
    J Genet Genomics; 2015 Aug; 42(8):413-21. PubMed ID: 26336798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.